AVEO Pharmaceuticals, Inc. (AVEO) was a big mover last session, as the company saw its shares rise by over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has now gained over 79% since Jun 6.
This biotechnology company has seen two positive estimate revisions over the past 30 days and its Zacks Consensus Estimate has moved higher over the same time frame, suggesting that more solid trading could be ahead for AVEO Pharmaceuticals. So make sure to keep an eye on this stock going forward to see if this recent move higher can turn into more strength down the road.
AVEO Pharmaceuticals currently has a Zacks Rank #2 (Buy) while its Earnings ESP is negative.
Some better-ranked stocks in the same sector include Actelion Ltd. (ALIOF), ANI Pharmaceuticals, Inc. (ANIP) and Biogen Idec Inc. (BIIB). All these stocks carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
AVEO PHARMACEUTICALS INC (AVEO): Free Stock Analysis Report
ACTELION LTD (ALIOF): Free Stock Analysis Report
ANI PHARMACEUTICALS INC (ANIP): Free Stock Analysis Report
BIOGEN IDEC INC (BIIB): Free Stock Analysis Report
Zacks Investment Research